The case is In Re Gardasil Products Liability Litigation, 3:22-MD-03036-KDB, US District Court for the Western District of ...

Gardasil and Gardasil 9 are together Merck's second best-selling product, with global sales of $8.58 billion in 2024. U.S. patent protection expires in 2028. The U.S. Centers for Disease Control ...

A class action lawsuit was filed against Merck & Co. (MRK) by Levi & Korsinsky on February 12, 2025. The plaintiffs ...

In the fourth quarter of 2024, worldwide sales of Gardasil products fell 17% to $1.6 billion, while for the full year they fell 3% to $7.6 billion. MSD has attributed the fall to lower demand in ...

And ever since Gardasil gained US Food and Drug Administration (FDA) approval last June, Merck has made no secret of its ambition to make it into a blockbuster product. In 2005, 1,500 of its sales ...

Gardasil 9 is the only HPV vaccine used in ... We may earn commission from links on this page, but we only recommend products we back.

(Bloomberg) -- Merck & Co.’s blockbuster vaccine Gardasil has had a roller-coaster ... distribution partner Chongqing Zhifei ...

More than 200 lawsuits demand warnings on Gardasil labels about an autoimmune disease called Postural Orthostatic Tachycardia Syndrome, or POTS, and Primary Ovarian Insufficiency, or POI ...

new products like Winrevair and strong performance of the Animal Health segment, partially offset by lower sales of Gardasil vaccine and diabetes drugs, Januvia and Janumet. Sales also beat the ...

The company began construction on the now open facility in 2019 to increase manufacturing capabilities for its Gardasil vaccine, which protects against HPV (Human papillomavirus). Merck last year ...

Picture this: It’s circa 2012 and I’m 13 years old, sitting awkwardly in my doctor’s office for my yearly physical, learning about the HPV vaccine. My doctor has just explained that the ...